We are live on
!
Find out more
Axsome Therapeutics
AXSM
AXSM
111 hedge funds and large institutions have $387M invested in Axsome Therapeutics in 2019 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 46 increasing their positions, 24 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
92% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 24
81% more call options, than puts
Call options by funds: $29.4M | Put options by funds: $16.2M
10% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 20
2% more funds holding
Funds holding: 109 → 111 (+2)
0.14% less ownership
Funds ownership: 55.11% → 54.97% (-0.14%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
19% less capital invested
Capital invested by funds: $476M → $387M (-$89.2M)
Holders
111
Holders Change
+2
Holders Change %
+1.83%
% of All Funds
2.43%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
22
Increased
46
Reduced
24
Closed
20
Calls
$29.4M
Puts
$16.2M
Net Calls
+$13.2M
Net Calls Change
-$4.43M
Top Buyers
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$17.4M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$12.5M |
| 3 |
Renaissance Technologies
New York
|
-$6.37M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$4.5M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.36M |
